RYTM — Rhythm Pharmaceuticals, Inc.
9 mentions in the last 24 hours · 0.04% of all mentions
Why people talked about RYTM (2026-11-03)
- Rhythm Pharmaceuticals secured a five-year term loan facility providing access to up to $750 million.
- The company amended its exclusive license agreement with LG Chem for the drug Bivamelagon.
- Investors purchased $162K worth of November 95 call options ahead of tomorrow's earnings report.
| Bluesky | 4 | community |
| GDELT | 4 | news |
| SEC EDGAR 8-K | 1 | filings |